Related Experiment Videos
Clonidine enhances delayed matching-to-sample performance by young and aged monkeys
1Department of Physiology & Endocrinology, Medical College of Georgia, Augusta 30912-3000.
Pharmacology, Biochemistry, and Behavior
|May 1, 1991
Summary
Clonidine, an alpha-2 noradrenergic agonist, improved cognitive performance in young and aged monkeys in a delayed matching-to-sample task. This enhancement lasted for at least 24 hours in both age groups.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Pharmacology
Background:
- Clonidine, an alpha-2 noradrenergic agonist, is known to affect cognitive functions in humans and animals.
- Existing research presents conflicting findings on clonidine's impact on delayed response (DR) performance in nonhuman primates.
Purpose of the Study:
- To investigate the effects of clonidine on cognitive performance, specifically delayed matching-to-sample (DMTS) task, in young and aged monkeys.
- To determine the duration of any observed cognitive enhancement.
Main Methods:
- Administration of clonidine to young and aged nonhuman primates.
- Assessment of cognitive performance using a delayed matching-to-sample (DMTS) task, a common measure of DR performance.
- Observation of performance changes over time.
Main Results:
- Clonidine administration led to a modest improvement in DMTS performance in both young and aged monkeys.
- The observed cognitive enhancement persisted for a minimum of 24 hours in both age cohorts.
Conclusions:
- Clonidine administration can enhance cognitive performance in nonhuman primates, including aged individuals.
- The cognitive benefits of clonidine on DMTS performance are sustained for at least 24 hours, suggesting potential therapeutic applications.